Low prevalence of highly sulfadoxine-resistant dihydropteroate synthase alleles in Plasmodium falciparum isolates in Benin

• Published in: Malaria journal 2021-02, Vol.20 (1), p.72-72, Article 72
• Main Authors: Svigel, Samaly Souza, Adeothy, Adicath, Kpemasse, Augustin, Houngbo, Ernest, Sianou, Antoine, Saliou, Ramani, Patton, Monica E, Dagnon, Fortune, Halsey, Eric S, Tchevoede, Alexis, Udhayakumar, Venkatachalam, Lucchi, Naomi W
• Format: Article
• Language: English
• Subjects: Alleles; Allelomorphism; Antimalarial agents; Artemisinin; Dihydrofolate reductase; Dihydropteroate synthase; Disease transmission; Drug resistance; Drug resistance in microorganisms; Drug therapy; Enrollments; Folic acid; Gene mutations; Genes; Genetic aspects; Genotypes; Haplotypes; Human diseases; Infections; Intermittent Preventive Treatment in Pregnant; Malaria; Metabolism; Mutants; Mutation; Nucleotides; Parasites; Parasitological research; Pfdhfr; Pfdhps; Plasmodium falciparum; Population genetics; Pyrimethamine; Seasonal Malaria Chemoprevention; Single-nucleotide polymorphism; Sulfadoxine; Sulfadoxine Pyrimethamine; Vector-borne diseases; Women
• ISSN: 1475-2875; 1475-2875
• DOI: 10.1186/s12936-021-03605-5

In 2004, in response to high levels of treatment failure associated with sulfadoxine-pyrimethamine (SP) resistance, Benin changed its first-line malaria treatment from SP to artemisinin-based combination therapy for treatment of uncomplicated Plasmodium falciparum malaria. Resistance to SP is conferred by accumulation of single nucleotide polymorphisms (SNPs) in P. falciparum genes involved in folate metabolism, dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps), targeted by pyrimethamine and sulfadoxine, respectively. Because SP is still used for intermittent preventive treatment in pregnant women (IPTp) and seasonal malaria chemoprevention (SMCP) in Benin, the prevalence of Pfdhfr and Pfdhps SNPs in P. falciparum isolates collected in 2017 were investigated. This study was carried out in two sites where the transmission of P. falciparum malaria is hyper-endemic: Klouékanmey and Djougou. Blood samples were collected from 178 febrile children 6-59 months old with confirmed uncomplicated P. falciparum malaria and were genotyped for SNPs associated with SP resistance. The Pfdhfr triple mutant IRN (N51I, C59R, and S108N) was the most prevalent (84.6%) haplotype and was commonly found with the Pfdhps single mutant A437G (50.5%) or with the Pfdhps double mutant S436A and A437G (33.7%). The quintuple mutant, Pfdhfr IRN/Pfdhps GE (A437G and K540E), was rarely observed (0.8%). The A581G and A613S mutant alleles were found in 2.6 and 3.9% of isolates, respectively. Six isolates (3.9%) were shown to harbour a mutation at codon I431V, recently identified in West African parasites. This study showed that Pfdhfr triple IRN mutants are near fixation in this population and that the highly sulfadoxine-resistant Pfdhps alleles are not widespread in Benin. These data support the continued use of SP for chemoprevention in these study sites, which should be complemented by periodic nationwide molecular surveillance to detect emergence of resistant genotypes.